Methadone and buprenorphine for the management of opioid dependence

TA114 Drug misuse - methadone and buprenorphine: review decision - November 2010 information

Appendix A: decision paper considered by the Institute's Guidance Executive

Appendix A: decision paper considered by the Institute's Guidance Executive (PDF 70 KB)

Drug misuse - methadone and buprenorphine: Review Proposal - August 2010 information

Appendix A: provisional matrix of stakeholders

Appendix A: provisional matrix of stakeholders (PDF 32 KB)

Appendix B: proposal paper presented to the Institute's Guidance Executive

Drug misuse - methadone and buprenorphine: Final appraisal determination information

Drug misuse - methadone and buprenorphine: Final appraisal determination document

Drug misuse - methadone and buprenorphine: Final appraisal determination document (PDF 104 KB)

Drug misuse - methadone and buprenorphine: Response to consultee and commentator comments on the ACD

Drug misuse - methadone and buprenorphine: Evaluation report

Overview

Overview (PDF 185 KB)

Assessment report

Drug misuse - methadone and buprenorphine: Final scope

Drug misuse - methadone and buprenorphine: Final protocol

Drug misuse - methadone and buprenorphine, comments on provisional matrix

Drug misuse - methadone and buprenorphine, comments on draft scope

Drug misuse - methadone and buprenorphine: Draft scope

Drug misuse - methadone and buprenorphine: Provisional matrix of consultees and commentators